Walgreens snags chief commercial officer from Optum
Jason Stenta, who has held roles at Optum and CVS Health, comes aboard as the company considers selling its stake in VillageMD and contends with shareholder litigation.
CMS to increase oversight on exchange brokers
The proposed rule comes after the CMS reported a growing number of complaints about health plan applications submitted by brokers.
Baxter unsure when North Carolina facility hit by Hurricane Helene will be operational
As access challenges to the site continue, Baxter has limited purchases of certain products to avoid stockpiling, manage inventory and minimize disruption to patient care.
SMG3Rx and Zebra establish clinical mobility to major medical system
SMG3Rx and Zebra Technologies integrated clinical mobility into a hospital network to support better patient outcomes. See how.
Unlocking the full potential of medical imaging data to drive value
Use Enlitic to improve medical imaging data quality and workflows to enhance operational efficiency!
CMS should take stronger stance on hospital pricing compliance: GAO
The CMS fails to check hospitals’ pricing data for accuracy and completeness, raising questions about whether the data can be used as intended to help payers and patients shop for services, according to the government agency.
Texas sues major PBMs, pharma companies over high insulin prices
The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx face growing criticism over their role in high drug costs — including a recent lawsuit from the Federal Trade Commission.
UnitedHealth sues CMS over Medicare Advantage star ratings
A handful of plans owned by the nation’s largest MA payer are the latest to ask the court to help raise their valuable quality scores.
Medicare tweaks rules for second round of drug price talks
The agency will offer earlier meetings with drugmakers as well as solicit more patient feedback on the process.
Lawmakers urge Biden administration to extend telehealth prescribing flexibilities for opioid use disorder
A bipartisan group of two dozen representatives pushed officials to preserve the pandemic-era prescribing changes for buprenorphine, arguing telehealth increases access and prevents overdoses.